NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Intellia Therapeutics (NTLA)

Technical Analysis Report for NASDAQ stock NTLA Intellia Therapeutics. Dated: 31 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics then click here. or read Experts views on Intellia Therapeutics or Forecast & share price targets of Intellia Therapeutics

Intellia Therapeutics Opened at 11.36 and Closed at: 10.68, which is -3.84% of previous session's close. It moved within a range of 10.60 and 11.44
The session was a Bearish session with an average volume of 1617501, which is -96.84% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.
• The stock has fallen, and its mid term trend is also negative and in a downtrend.
• The stock has fallen, and its long term trend is also negative and in a downtrend.

A Dead cross was found 3 days back on long term averages

Support for tomorrow is 10.22 and resistance for tomorrow is 11.06
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 10.37, 10.07 resistance for tomorrow's hourly charts is 11.21, 11.75

10 Day SMA for Intellia Therapeutics (NTLA) is 10.93 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Intellia Therapeutics (NTLA) is 12.34 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Intellia Therapeutics (NTLA) is 13.65 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 13.62 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Intellia Therapeutics is 12.95 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Intellia Therapeutics is at 12.34 and 200 DMA is at 12.95, while 50 DMA and 100 DMA are at 13.65 and 13.62 respectively

Intellia Therapeutics (NTLA) moving average of 20 SMA is at 12.34 and 20 EMA is at 12.06

Intellia Therapeutics (NTLA) moving average of 50 SMA is at 13.65 and 50 EMA is at 13.13

Intellia Therapeutics (NTLA) moving average of 100 SMA is at 13.62 and 100 EMA is at 13.34

Intellia Therapeutics (NTLA) moving average of 200 SMA is at 12.95 and 200 EMA is at 12.91

Vertex Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Vertex Pharmaceuticals, about 30.04% more returns!

Vericel Corporation has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Vericel Corporation, about 36.58% more returns!

United Therapeutics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in United Therapeutics, about 30.53% more returns!

Tiziana Life has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Tiziana Life, about 20.44% more returns!

Scholar Rock has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Scholar Rock, about 22.32% more returns!

Scynexis Inc has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Scynexis Inc, about 43.46% more returns!

Rockwell Medical has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Rockwell Medical, about 56.56% more returns!

Neogenomics Inc has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Neogenomics Inc, about 44.14% more returns!

Lakeland Industries has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Lakeland Industries, about 34.97% more returns!

Aceto Corporation has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Aceto Corporation, about 44.85% more returns!

Argenx Se has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Argenx Se, about 31.5% more returns!

Celcuity Inc has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Celcuity Inc, about 13.34% more returns!

Cogentix Medical has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Cogentix Medical, about 36.93% more returns!

Collplant Holdings has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Collplant Holdings, about 13.69% more returns!

Collegium Pharmaceutical has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Collegium Pharmaceutical, about 35.81% more returns!

Curis Inc has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Curis Inc, about 34.31% more returns!

Crinetics Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Crinetics Pharmaceuticals, about 38.68% more returns!

Immutep has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Immutep, about 23.13% more returns!

Inmune Bio has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Inmune Bio, about 38.69% more returns!

Intellia Therapeutics Technical analysis of indicators

Price action analysis of Intellia Therapeutics (NTLA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.

MACD generated a SELL signal for Intellia Therapeutics in short term and the sell signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Intellia Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 10.94 and Intellia Therapeutics NTLA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Intellia Therapeutics NTLA stock. Volume based technical analysis of Intellia Therapeutics NTLA stock is negative.

Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And NTLA Experts View which covers a lot of information including buying and selling signals

NTLA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Intellia Therapeutics or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet